GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytori Cell Research Institute Inc (TSE:3750) » Definitions » Policy Acquisition Expense

Cytori Cell Research Institute (TSE:3750) Policy Acquisition Expense


View and export this data going back to 2004. Start your Free Trial

What is Cytori Cell Research Institute Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Cytori Cell Research Institute (TSE:3750) Business Description

Traded in Other Exchanges
N/A
Address
1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
Cytori Cell Research Institute Inc developing a new clinical approach to cell therapy to provide better medical care to patients by providing medical care that responds to unmet medical needs based on innovative regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.